Apigenin for Parkinson's Disease

Also known as: 4',5,7-trihydroxyflavone, Chamomile extract

Apigenin's anti-neuroinflammatory effects and NAD+ preservation target core PD pathology.

Mechanism of Action

Apigenin inhibits microglial-driven neuroinflammation, preserves NAD+ through CD38 inhibition for mitochondrial function, and reduces α-synuclein-induced oxidative stress. It also promotes BDNF expression for dopaminergic neuron support.

General mechanism: Flavone. CD38 inhibitor (NAD+ preservation), NF-κB suppressor, CK2/PI3K inhibitor, BDNF promoter.

Current Evidence

Preclinical PD models show neuroprotection. CD38 role in PD is an emerging research area. No clinical trials.

Clinical Status: Preclinical. Available as supplement.

Safety Profile

Very safe. Naturally present in diet. Sedative at high doses (chamomile effect). No significant drug interactions.

Key Research Questions

View glossary entry →

← Back to Parkinson's Disease Research